Back
Open Access

What makes it stentless? Development and internal validation of bailout risk score in DCB-only PCI

Session: Personalised PCI: special populations, innovative devices and tailored therapy
Topic: Revascularisation
Speaker: Doctor L. Iossa (Mercogliano, IT)
Event: EAPCI Summit 2026

Congress Presentation

Add to my library

Like

About the speaker

Doctor Luigi Alberto Iossa

Montevergine Clinic, Mercogliano (Italy)
0 follower

6 more presentations in this session

Cardio-kidney-metabolic phenotypes determine residual cardiovascular risk after acute coronary syndromes

Speaker: Miss Y. Wang (Zurich, CH)

Access
Abstract
Like
Thumbnail

Impact of cardio-oncology services on care and outcomes of STEMI patients with active cancer

Speaker: Doctor M. Dafaalla (Stoke-on-Trent, GB)

Access
Abstract
Like
Thumbnail

Impact of sex on residual angina after percutaneous coronary interventions

Speaker: Doctor D. Munhoz (Aalst, BE)

Access
Abstract
Like
Thumbnail

Polymer-free amphilimus-eluting stents vs. biodegradable-polymer everolimus-eluting stents in all-comers undergoing pci: 2-year results of the PARTHENOPE trial

Speaker: Associate Professor R. Piccolo (Naples, IT)

Access
Abstract
Like
Thumbnail

Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in acute coronary syndrome (ACS dragon-registry)

Speaker: Professor R. Januszek (Krakow, PL)

Access
Abstract
Like
Thumbnail

Access the full session

Personalised PCI: special populations, innovative devices and tailored therapy

Speakers: Doctor L. Iossa, Miss Y. Wang, Doctor M. Dafaalla, Doctor D. Munhoz, Associate Professor R. Piccolo...
Access
Like
Thumbnail

About the event

Image

EAPCI Summit 2026

19 February - 20 February 2026

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources